Compare Divis Laboratories with IPCA Labs - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs IPCA LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES IPCA LABS DIVIS LABORATORIES/
IPCA LABS
 
P/E (TTM) x 61.3 25.6 239.8% View Chart
P/BV x 14.1 5.4 259.1% View Chart
Dividend Yield % 0.4 0.4 102.2%  

Financials

 DIVIS LABORATORIES   IPCA LABS
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-21
IPCA LABS
Mar-21
DIVIS LABORATORIES/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs3,9132,456 159.4%   
Low Rs1,8241,371 133.0%   
Sales per share (Unadj.) Rs262.5423.3 62.0%  
Earnings per share (Unadj.) Rs74.790.6 82.5%  
Cash flow per share (Unadj.) Rs84.4107.1 78.8%  
Dividends per share (Unadj.) Rs20.008.00 250.0%  
Avg Dividend yield %0.70.4 166.8%  
Book value per share (Unadj.) Rs350.1370.6 94.5%  
Shares outstanding (eoy) m265.47126.85 209.3%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x10.94.5 241.7%   
Avg P/E ratio x38.421.1 181.6%  
P/CF ratio (eoy) x34.017.9 190.2%  
Price / Book Value ratio x8.25.2 158.7%  
Dividend payout %26.88.8 302.9%   
Avg Mkt Cap Rs m761,517242,728 313.7%   
No. of employees `000NANA-   
Total wages/salary Rs m8,25810,136 81.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m69,69453,699 129.8%  
Other income Rs m6271,292 48.5%   
Total revenues Rs m70,32154,991 127.9%   
Gross profit Rs m28,61114,812 193.2%  
Depreciation Rs m2,5562,092 122.2%   
Interest Rs m21123 17.1%   
Profit before tax Rs m26,66013,890 191.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6,8182,401 283.9%   
Profit after tax Rs m19,84311,488 172.7%  
Gross profit margin %41.127.6 148.8%  
Effective tax rate %25.617.3 147.9%   
Net profit margin %28.521.4 133.1%  
BALANCE SHEET DATA
Current assets Rs m67,90634,370 197.6%   
Current liabilities Rs m17,28411,331 152.5%   
Net working cap to sales %72.642.9 169.3%  
Current ratio x3.93.0 129.5%  
Inventory Days Days1049 19.6%  
Debtors Days Days8786 15,913.2%  
Net fixed assets Rs m45,96326,295 174.8%   
Share capital Rs m531254 209.3%   
"Free" reserves Rs m92,41546,763 197.6%   
Net worth Rs m92,94647,017 197.7%   
Long term debt Rs m0365 0.0%   
Total assets Rs m113,86960,664 187.7%  
Interest coverage x1,270.5114.2 1,112.5%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.60.9 69.1%   
Return on assets %17.419.1 91.1%  
Return on equity %21.324.4 87.4%  
Return on capital %28.729.6 97.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m027,172 0.0%   
Fx outflow Rs m07,949 0.0%   
Net fx Rs m019,223 0.0%   
CASH FLOW
From Operations Rs m19,46910,901 178.6%  
From Investments Rs m751-5,207 -14.4%  
From Financial Activity Rs m-349-3,058 11.4%  
Net Cashflow Rs m19,8722,636 753.8%  

Share Holding

Indian Promoters % 52.0 46.3 112.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 37.1 43.9 84.4%  
FIIs % 20.7 18.5 112.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.1 53.7 89.5%  
Shareholders   223,403 95,239 234.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   CIPLA  BACIL PHARMA  UNICHEM LAB  ERIS LIFESCIENCES  BAFNA PHARMA  



Today's Market

Bloodbath on Dalal Street: 6 Reasons Why Sensex Slumped 1,688 Points Today(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended deep in the red.

Related Views on News

DIVIS LABORATORIES 2020-21 Annual Report Analysis (Annual Result Update)

Oct 20, 2021 | Updated on Oct 20, 2021

Here's an analysis of the annual report of DIVIS LABORATORIES for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

IPCA LABS 2020-21 Annual Report Analysis (Annual Result Update)

Sep 6, 2021 | Updated on Sep 6, 2021

Here's an analysis of the annual report of IPCA LABS for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of IPCA LABS. Also includes updates on the valuation of IPCA LABS.

DIVIS LABORATORIES Announces Quarterly Results (1QFY22); Net Profit Up 13.2% (Quarterly Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

For the quarter ended June 2021, DIVIS LABORATORIES has posted a net profit of Rs 6 bn (up 13.2% YoY). Sales on the other hand came in at Rs 20 bn (up 13.3% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

IPCA LABS Announces Quarterly Results (1QFY22); Net Profit Down 30.8% (Quarterly Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

For the quarter ended June 2021, IPCA LABS has posted a net profit of Rs 3 bn (down 30.8% YoY). Sales on the other hand came in at Rs 16 bn (up 2.0% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (4QFY21); Net Profit Up 29.3% (Quarterly Result Update)

Jun 28, 2021 | Updated on Jun 28, 2021

For the quarter ended March 2021, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 29.3% YoY). Sales on the other hand came in at Rs 18 bn (up 28.7% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

How to Hit Rs 100 Crore Wealth in Your Lifetime(Equitymaster Wealth)

Nov 15, 2021

This is how you can achieve the ambitious goal of a net worth of Rs 100 crore.

Don't Sell these Stocks if the Market Falls(Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing.(Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DIVIS LABORATORIES SHARE PRICE


Nov 26, 2021 (Close)

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES - PFIZER COMPARISON

COMPARE DIVIS LABORATORIES WITH

MARKET STATS